These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 24075764

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
    Brousseau ME, Diffenderfer MR, Millar JS, Nartsupha C, Asztalos BF, Welty FK, Wolfe ML, Rudling M, Björkhem I, Angelin B, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1057-64. PubMed ID: 15761191
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia.
    Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA.
    Am J Clin Nutr; 1986 Sep; 44(3):353-61. PubMed ID: 3751956
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels.
    Jakulj L, Trip MD, Sudhop T, von Bergmann K, Kastelein JJ, Vissers MN.
    J Lipid Res; 2005 Dec; 46(12):2692-8. PubMed ID: 16162943
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Caveolin-1 is not required for murine intestinal cholesterol transport.
    Valasek MA, Weng J, Shaul PW, Anderson RG, Repa JJ.
    J Biol Chem; 2005 Jul 29; 280(30):28103-9. PubMed ID: 15919660
    [Abstract] [Full Text] [Related]

  • 32. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).
    Davis HR, Basso F, Hoos LM, Tetzloff G, Lally SM, Altmann SW.
    Atheroscler Suppl; 2008 Sep 29; 9(2):77-81. PubMed ID: 18585981
    [Abstract] [Full Text] [Related]

  • 33. Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats.
    Oswald S, Westrup S, Grube M, Kroemer HK, Weitschies W, Siegmund W.
    J Pharmacol Exp Ther; 2006 Sep 29; 318(3):1293-9. PubMed ID: 16772539
    [Abstract] [Full Text] [Related]

  • 34. Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways.
    Turley SD.
    Clin Cardiol; 2004 Jun 29; 27(6 Suppl 3):III16-21. PubMed ID: 15239487
    [Abstract] [Full Text] [Related]

  • 35. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
    Knöpfel M, Davies JP, Duong PT, Kvaernø L, Carreira EM, Phillips MC, Ioannou YA, Hauser H.
    Biochim Biophys Acta; 2007 Sep 29; 1771(9):1140-7. PubMed ID: 17689140
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1-5 SPECT in ApoE-/- Mice Fed the Paigen Diet.
    Dumas LS, Briand F, Clerc R, Brousseau E, Montemagno C, Ahmadi M, Bacot S, Soubies A, Perret P, Riou LM, Devoogdt N, Lahoutte T, Barone-Rochette G, Fagret D, Ghezzi C, Sulpice T, Broisat A.
    J Nucl Med; 2017 Jul 29; 58(7):1088-1093. PubMed ID: 28280218
    [Abstract] [Full Text] [Related]

  • 37. Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels.
    Mangat R, Warnakula S, Wang Y, Russell JC, Uwiera R, Vine DF, Proctor SD.
    Atheroscler Suppl; 2010 Jun 29; 11(1):17-24. PubMed ID: 20471328
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of cholesterol absorption with CP-148,623 lowers serum cholesterol in humans.
    Harris WS, Windsor SL, Newton FA, Gelfand RA.
    Clin Pharmacol Ther; 1997 Mar 29; 61(3):385-9. PubMed ID: 9084463
    [Abstract] [Full Text] [Related]

  • 39. The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies.
    Stellaard F, von Bergmann K, Sudhop T, Lütjohann D.
    J Steroid Biochem Mol Biol; 2017 May 29; 169():111-122. PubMed ID: 27060336
    [Abstract] [Full Text] [Related]

  • 40. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 29; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.